GetTopicDetailResponse(id=5bcd1183e12, topicName=miR-17-92, introduction=miR-17-92, content=null, image=null, comments=4, allHits=1091, url=https://h5.medsci.cn/topic?id=11837, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=57114, tagList=[TagDto(tagId=57114, tagName=miR-17-92)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2069307, encodeId=1c85206930ece, content=<a href='/topic/show?id=5bcd1183e12' target=_blank style='color:#2F92EE;'>#miR-17-92#</a>, objectTitle=Blood：創(chuàng)新藥物MIR17PTi，miR-17-92前體抑制劑，在多發(fā)性骨髓瘤中的應(yīng)用, objectType=article, longId=144392, objectId=5e3914439204, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e3914439204, replyNumber=0, likeNumber=91, createdTime=2019-03-26, rootId=0, userName=wfang545, userId=cfa576, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e3914439204, moduleTitle=Blood：創(chuàng)新藥物MIR17PTi，miR-17-92前體抑制劑，在多發(fā)性骨髓瘤中的應(yīng)用, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5e3914439204)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2069306, encodeId=c4632069306e5, content=<a href='/topic/show?id=5bcd1183e12' target=_blank style='color:#2F92EE;'>#miR-17-92#</a>, objectTitle=Blood：在慢性移植物抗宿主病中發(fā)現(xiàn)一種新的miRNA——miR-17-92，有望成為預(yù)防cGVHD新靶點(diǎn), objectType=article, longId=132384, objectId=121e132384a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=121e132384a7, replyNumber=0, likeNumber=88, createdTime=2018-07-29, rootId=0, userName=wfang545, userId=cfa576, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=121e132384a7, moduleTitle=Blood：在慢性移植物抗宿主病中發(fā)現(xiàn)一種新的miRNA——miR-17-92，有望成為預(yù)防cGVHD新靶點(diǎn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=121e132384a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2069305, encodeId=9b75206930538, content=<a href='/topic/show?id=5bcd1183e12' target=_blank style='color:#2F92EE;'>#miR-17-92#</a>, objectTitle=SCI REP：在各種腫瘤中miR-17-92基因簇高表達(dá)的預(yù)后價(jià)值分析！, objectType=article, longId=110465, objectId=c6d1110465fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6d1110465fc, replyNumber=0, likeNumber=76, createdTime=2017-12-05, rootId=0, userName=wfang545, userId=cfa576, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6d1110465fc, moduleTitle=SCI REP：在各種腫瘤中miR-17-92基因簇高表達(dá)的預(yù)后價(jià)值分析！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c6d1110465fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2069304, encodeId=933f2069304be, content=<a href='/topic/show?id=5bcd1183e12' target=_blank style='color:#2F92EE;'>#miR-17-92#</a>, objectTitle=Oncotarget：miR-17-92家族能有效預(yù)測(cè)癌癥患者預(yù)后, objectType=article, longId=106266, objectId=9a731062660b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a731062660b, replyNumber=0, likeNumber=97, createdTime=2018-06-10, rootId=0, userName=wfang545, userId=cfa576, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a731062660b, moduleTitle=Oncotarget：miR-17-92家族能有效預(yù)測(cè)癌癥患者預(yù)后, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9a731062660b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
